137 related articles for article (PubMed ID: 428428)
1. Potentiating mechanism of bradykinin action on smooth muscle by sulfhydryl compounds.
Iso T; Nishimura K; Oya M; Iwao J
Eur J Pharmacol; 1979 Mar; 54(3):303-5. PubMed ID: 428428
[TBL] [Abstract][Full Text] [Related]
2. Inhibitor of angiotensin I converting enzyme: (4R)-3-[(2S)-3-mercapto-2-methylpropanoyl]-4-thiazolidinecarboxylic acid (YS-980).
Funae Y; Komori T; Sasaki D; Yamamoto K
Biochem Pharmacol; 1980 Jun; 29(11):1543-7. PubMed ID: 6249321
[No Abstract] [Full Text] [Related]
3. A new potent inhibitor of converting enzyme: (2R,4R)-2-(2-hydroxyphenyl)-3-(3-mercaptopropionyl)-4-thiazolidinecarboxylic acid(SA446).
Iso T; Yamauchi H; Suda H; Nakata K; Nishimura K; Iwao J
Jpn J Pharmacol; 1981 Dec; 31(6):875-82. PubMed ID: 6174764
[TBL] [Abstract][Full Text] [Related]
4. Comparative study on the mechanism of bradykinin potentiation induced by bradykinin-potentiating peptide 9a, enalaprilat and kinin-potentiating peptide.
Rodrigues MS; Schaffel R; Assreuy J
Eur J Pharmacol; 1992 Jun; 216(3):357-62. PubMed ID: 1330581
[TBL] [Abstract][Full Text] [Related]
5. Effect of indomethacin and prostaglandin on the smooth muscle contracting activity of angiotensin and other agonists.
Aboulafia J; Mendes GB; Miyamoto ME; Paiva AC; Paiva TB
Br J Pharmacol; 1976 Oct; 58(2):223-8. PubMed ID: 974384
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and pharmacological screening of new angiotensin converting enzyme inhibitors.
Gubert S; Braso MA; Sacristán A; Ortiz JA
Farmaco; 1990 Jan; 45(1):59-79. PubMed ID: 2186741
[TBL] [Abstract][Full Text] [Related]
7. Antihypertensive effects of the novel converting-enzyme inhibitor YS 980 in spontaneously hypertensive rats.
Unger T; Rockhold RW; Bönner G; Rascher W; Schaz K; Speck G; Schömig A; Ganten D
Clin Exp Hypertens (1978); 1981; 3(1):121-40. PubMed ID: 6258887
[No Abstract] [Full Text] [Related]
8. A novel orally active converting-enzyme inhibitor YS 980: effects on blood pressure in spontaneously hypertensive rats.
Unger T; Rockhold RW; Schaz K; Vescel P; Bönner G; Rascher W; Ganten D
Clin Sci (Lond); 1979 Dec; 57 Suppl 5():157s-160s. PubMed ID: 232020
[TBL] [Abstract][Full Text] [Related]
9. Potentiation of bradykinin effects and inhibition of kininase activity in isolated smooth muscle.
Schaffel R; Rodrigues MS; Assreuy J
Can J Physiol Pharmacol; 1991 Jul; 69(7):904-8. PubMed ID: 1659490
[TBL] [Abstract][Full Text] [Related]
10. Mechanism of the inhibitory actions of some spasmogens on the bradykinin relaxation of the guinea-pig ileum.
Hall DW; Bonta IL; Verhoef ER
Eur J Pharmacol; 1974 Mar; 25(3):308-15. PubMed ID: 4363949
[No Abstract] [Full Text] [Related]
11. Bradykinin-induced contractions of canine prostate and bladder: effect of angiotensin-converting enzyme inhibition.
Steidle CP; Cohen ML; Neubauer BL
J Urol; 1990 Aug; 144(2 Pt 1):390-2. PubMed ID: 2165184
[TBL] [Abstract][Full Text] [Related]
12. Effects of YS-980, an orally active converting enzyme inhibitor, on blood pressure in normotensive and hypertensive rats.
Komori T; Yamamoto K
Jpn J Pharmacol; 1981 Jun; 31(3):401-7. PubMed ID: 6273629
[TBL] [Abstract][Full Text] [Related]
13. Potentiating effects of bradykinin-related substances on bradykinin-induced contraction of guinea pig ileum and hypotension in rats.
Naruse M; Yamanami S; Shuto K; Sakakibara S; Kimura T
Chem Pharm Bull (Tokyo); 1981 Nov; 29(11):3369-74. PubMed ID: 7337937
[No Abstract] [Full Text] [Related]
14. The mechanism of action of two bradykinin-potentiating peptides on isolated smooth muscle.
Ufkes JG; Aarsen PN; van der Meer C
Eur J Pharmacol; 1977 Jul; 44(2):89-97. PubMed ID: 195822
[TBL] [Abstract][Full Text] [Related]
15. Cardiovascular and gastrointestinal effects of bradykinin and its potentiation by thiols in rats.
Sherman WT; Gautieri RF
J Pharm Sci; 1969 Aug; 58(8):971-5. PubMed ID: 5344532
[No Abstract] [Full Text] [Related]
16. General pharmacological properties of the potent angiotensin converting enzyme inhibitor rentiapril.
Yamauchi H; Nishimura K; Nakata K; Suda H; Iso T; Shimizu M; Hiramatsu Y
Arzneimittelforschung; 1987 Feb; 37(2):157-64. PubMed ID: 3034298
[TBL] [Abstract][Full Text] [Related]
17. Structure and effects of a kinin potentiating fraction F (AppF) isolated from Agkistrodon piscivorus piscivorus venom.
Ferreira LA; Möllring T; Lebrun FL; Raida M; Znottka R; Habermehl GG
Toxicon; 1995 Oct; 33(10):1313-9. PubMed ID: 8599182
[TBL] [Abstract][Full Text] [Related]
18. Potentiation of some bradykinin effects by thiol compounds.
Cîrstea M
Br J Pharmacol Chemother; 1965 Oct; 25(2):405-10. PubMed ID: 5866720
[No Abstract] [Full Text] [Related]
19. [Potentiative effects of angiotensin converting enzyme inhibitors on carrageenan-induced edema in rats].
Suda H; Yamauchi H; Iso T
Nihon Yakurigaku Zasshi; 1982 Dec; 80(6):517-23. PubMed ID: 6298082
[TBL] [Abstract][Full Text] [Related]
20. [Contractile activities of synthetic bradykinin fragments on guinea pig ileum].
Kameyama T; Sasaki KI; Nabeshima J
Yakugaku Zasshi; 1970 Aug; 90(8):1006-11. PubMed ID: 5466153
[No Abstract] [Full Text] [Related]
[Next] [New Search]
